Trial record 1 of 1 for:
NCT01735643
Lifestyle Intervention With an Interactive Video Game for Type 2 Diabetes Patients
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01735643 |
|
Recruitment Status :
Completed
First Posted : November 28, 2012
Last Update Posted : November 28, 2012
|
Sponsor:
West German Center of Diabetes and Health
Collaborators:
Novartis Pharmaceuticals
Nintendo of Europe GmbH
Information provided by (Responsible Party):
Stephan Martin, West German Center of Diabetes and Health
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Brief Summary:
Due to overweight and unhealthy lifestyle the number of patients with type 2 diabetes mellitus is increasing. Although in early phases the disease might be successfully treated by lifestyle change patients lack for motivation. Instead of increasing anti-diabetic medication a highly motivational system with low inhibition threshold is needed. Therefore, the investigators analyzed if regular use of the interactive videogame Wii Fit Plus over 12 weeks is able to improve HbA1c and weight in patients with type 2 diabetes.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Type 2 Diabetes Mellitus | Device: interactive videogame Wii Fit Plus Other: waiting | Early Phase 1 |
Patients with type 2 diabetes were recruited via treating physicians or articles in magazines and newspapers. Participants were randomized in an intervention and a control group. The intervention group was sent the Wii, the balance board and the interactive video game Wii Fit Plus and were instructed to use these items 30 minutes each day during the next 12 weeks. The control group got the items 12 weeks later. At begin and after 12 weeks of intervention participants (and additionally for the control group: after 12 weeks of waiting phase) sent their health parameters, which had been measured in the context of the disease management program type 2 diabetes as well as questionnaires about physical activity and quality of life to the study center.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 220 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Spielend zu Mehr Bewegung - Lebensstilintervention Durch Das Interaktive Video-spiel "Wii Fit Plus" Bei Personen Mit Typ-2-Diabetes Mellitus |
| Study Start Date : | January 2011 |
| Actual Primary Completion Date : | September 2012 |
| Actual Study Completion Date : | September 2012 |
Resource links provided by the National Library of Medicine
Genetics Home Reference related topics:
Type 2 diabetes
| Arm | Intervention/treatment |
|---|---|
| Experimental: interactive videogame intervention |
Device: interactive videogame Wii Fit Plus
Use of the interactive videogame Wii Fit Plus für 12 weeks.
Other Name: Wii Fit Plus |
| Experimental: waiting group |
Other: waiting
waiting for 12 weeks |
Primary Outcome Measures :
- HbA1c [ Time Frame: 12 weeks ]
Secondary Outcome Measures :
- weight [ Time Frame: 12 weeks ]
Information from the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 50 Years to 75 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- type 2 diabetes mellitus
- diabetes duration < 5 years
- age 50-75 years
- body mass index > or equal to 27 kg/m2
- participating in the disease management programme type 2 diabetes mellitus
- physical and mental able for study participation
Exclusion Criteria:
- insulin or antidiabetic medication (exception: Metformin and DPP-IV-Inhibitors)
- regular physical activity
- depression
- tumors
- change of smoking status during the past 6 months or during the study
- participation in other studies during the past 6 months
Information from the National Library of Medicine
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01735643
Locations
| Germany | |
| West German Center of Diabetes and Health | |
| Düsseldorf, Germany, 40591 | |
Sponsors and Collaborators
West German Center of Diabetes and Health
Novartis Pharmaceuticals
Nintendo of Europe GmbH
Investigators
| Principal Investigator: | Stephan Martin, MD | West German Center of Diabetes and Health |
Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Stephan Martin, MD, West German Center of Diabetes and Health |
| ClinicalTrials.gov Identifier: | NCT01735643 History of Changes |
| Other Study ID Numbers: |
Wii study |
| First Posted: | November 28, 2012 Key Record Dates |
| Last Update Posted: | November 28, 2012 |
| Last Verified: | November 2012 |
Keywords provided by Stephan Martin, West German Center of Diabetes and Health:
|
type 2 diabetes mellitus physical activity lifestyle change motivation patient empowerment |
Additional relevant MeSH terms:
|
Diabetes Mellitus Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |